Lalitha Podila

401 total citations
4 papers, 206 citations indexed

About

Lalitha Podila is a scholar working on Pediatrics, Perinatology and Child Health, Molecular Biology and Oncology. According to data from OpenAlex, Lalitha Podila has authored 4 papers receiving a total of 206 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pediatrics, Perinatology and Child Health, 2 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Lalitha Podila's work include Drug Transport and Resistance Mechanisms (2 papers), Pharmacological Effects and Toxicity Studies (2 papers) and Hepatitis B Virus Studies (1 paper). Lalitha Podila is often cited by papers focused on Drug Transport and Resistance Mechanisms (2 papers), Pharmacological Effects and Toxicity Studies (2 papers) and Hepatitis B Virus Studies (1 paper). Lalitha Podila collaborates with scholars based in United States, Germany and France. Lalitha Podila's co-authors include Mitchell E. Taub, Rucha Sane, Gerhard Nehmiz, Gerhard Steinmann, Donald Tweedie, Arvind Mathur, Stephen Olson, Tarik Asselah, Qian Huang and Jerry O. Stern and has published in prestigious journals such as Journal of Hepatology, Journal of Pharmacology and Experimental Therapeutics and Journal of Pharmaceutical Sciences.

In The Last Decade

Lalitha Podila

4 papers receiving 200 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lalitha Podila United States 4 147 80 53 42 31 4 206
S. Kawauchi Japan 7 189 1.3× 89 1.1× 115 2.2× 64 1.5× 14 0.5× 7 339
Päivi Äänismaa Switzerland 10 213 1.4× 84 1.1× 140 2.6× 21 0.5× 20 0.6× 11 380
Lawton Shick United States 7 119 0.8× 31 0.4× 45 0.8× 55 1.3× 100 3.2× 8 327
Christoph Wenzel Germany 8 94 0.6× 34 0.4× 41 0.8× 83 2.0× 14 0.5× 14 208
Masahiro Shimomura Japan 9 101 0.7× 66 0.8× 46 0.9× 26 0.6× 8 0.3× 14 213
Uta Eckhardt Switzerland 6 358 2.4× 176 2.2× 66 1.2× 58 1.4× 18 0.6× 9 407
Cornelia Remmler Germany 7 246 1.7× 160 2.0× 72 1.4× 75 1.8× 5 0.2× 8 367
William D. Hedrich United States 8 101 0.7× 26 0.3× 64 1.2× 73 1.7× 5 0.2× 13 261
Saki Izumi Japan 10 385 2.6× 198 2.5× 66 1.2× 192 4.6× 8 0.3× 13 467
Stéphanie Beauchemin Canada 8 65 0.4× 58 0.7× 36 0.7× 29 0.7× 3 0.1× 13 208

Countries citing papers authored by Lalitha Podila

Since Specialization
Citations

This map shows the geographic impact of Lalitha Podila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lalitha Podila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lalitha Podila more than expected).

Fields of papers citing papers by Lalitha Podila

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lalitha Podila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lalitha Podila. The network helps show where Lalitha Podila may publish in the future.

Co-authorship network of co-authors of Lalitha Podila

This figure shows the co-authorship network connecting the top 25 collaborators of Lalitha Podila. A scholar is included among the top collaborators of Lalitha Podila based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lalitha Podila. Lalitha Podila is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Sane, Rucha, Gerhard Steinmann, Yongmei Li, et al.. (2014). Mechanisms Underlying Benign and Reversible Unconjugated Hyperbilirubinemia Observed with Faldaprevir Administration in Hepatitis C Virus Patients. Journal of Pharmacology and Experimental Therapeutics. 351(2). 403–412. 22 indexed citations
2.
3.
Sane, Rucha, Lalitha Podila, Arvind Mathur, et al.. (2011). 1236 MECHANISMS OF ISOLATED UNCONJUGATED HYPERBILIRUBINEMIA INDUCED BY THE HCV NS3/4A PROTEASE INHIBITOR BI201335. Journal of Hepatology. 54. S488–S488. 17 indexed citations
4.
Taub, Mitchell E., et al.. (2005). FUNCTIONAL ASSESSMENT OF MULTIPLE P-GLYCOPROTEIN (P-GP) PROBE SUBSTRATES: INFLUENCE OF CELL LINE AND MODULATOR CONCENTRATION ON P-GP ACTIVITY. Drug Metabolism and Disposition. 33(11). 1679–1687. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Kawauchi Breakdown of academic impact, for papers by Päivi Äänismaa Breakdown of academic impact, for papers by Lawton Shick Breakdown of academic impact, for papers by Christoph Wenzel Breakdown of academic impact, for papers by Masahiro Shimomura Breakdown of academic impact, for papers by Uta Eckhardt Breakdown of academic impact, for papers by Cornelia Remmler Breakdown of academic impact, for papers by William D. Hedrich Breakdown of academic impact, for papers by Saki Izumi Breakdown of academic impact, for papers by Stéphanie Beauchemin
Rankless by CCL
2026